A joint project between Germany's Max Planck Institute of Psychiatry and the Douglas Research Centre, this initiative focuses on advancing our understanding of how adversity is biologically embedded to increase the risk of psychiatric disorders. The Centre will offer possibilities for research into adversity by combining unique resources, including animal models, cutting-edge sequencing, big data analytics, and large clinical and epidemiological cohorts. Training workshops and research support for joint projects will promote collaboration between the two partner institutions and offer educational opportunities for graduate students and clinician-scientists.
Project details
Project start date: April 1, 2021
Max Planck Institute of Psychiatry contribution: $2,500,000
McGill contribution: $2,500,000
Project Partners
German Principal Investigator: Dr. Elisabeth Binder
Director and Scientific Member at the Max Planck Institute of Psychiatry; Research group leader at the Max-Planck Institute of Psychiatry
Canadian Principal Investigator: Dr. Gustavo Turecki
Scientific Director, Douglas Research Centre; Chair, Department of Psychiatry, McGill University
Other project partners
Douglas Research Centre
- Michael Meaney, PhD
- Naguib Mechawar, PhD
- Corina Nagy, PhD
- Patricia Silveira, MD, PhD
- Claire-Dominique Walker, PhD
- Tie Yuan Zhang, PhD
Max Planck Institute of Psychiatry
- Silvia Cappello, PhD
- Jan Deussing, PhD
- Bertram Müller-Myhsok MD
- Mathias Schmidt, PhD
- Nikos Koutsouleris, MD
